| Sara R Husarik, ARNP | |
|
1706 Meridian S, Suite 120, Puyallup, WA 98371-7516 | |
| (253) 848-8797 | |
| (253) 446-3239 |
| Full Name | Sara R Husarik |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Pediatrics |
| Location | 1706 Meridian S, Puyallup, Washington |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003894965 | NPI | - | NPPES |
| 1018068 | Other | WA | DSHS NUMBER |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | RN00126475 (Washington) | Secondary |
| 363LP0200X | Nurse Practitioner - Pediatrics | AP3004299 (Washington) | Primary |
| Entity Name | Multicare Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497766638 PECOS PAC ID: 7719899897 Enrollment ID: O20031105000760 |
News Archive
Lenox Hill Radiology, a wholly owned subsidiary of RadNet, Inc., a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of owned and operated outpatient imaging centers, announces that 3D mammography, the latest innovation in breast cancer screening, is now available at its 79th Street location on the Upper West Side.
Champions Biotechnology, Inc., a company engaged in the development of advanced preclinical platforms and tumor specific data to enhance the value of oncology drugs, today announced its financial results for the fiscal year ended April 30, 2010.
Minneapolis Heart Institute Foundation research cardiologist Dr. Michael Miedema is the lead author of a paper published by Circulation - Cardiovascular Imaging, a journal of the American Heart Association, that suggests a connection between an adult's height and the prevalence of coronary artery calcium (CAC), a direct marker of plaque in the arteries that feed the heart.
Neuraltus Pharmaceuticals, a privately held biopharmaceutical company dedicated to developing and commercializing high-impact therapeutics that address critical unmet needs, primarily in the treatment of neurodegenerative diseases, announced today the Company has achieved last patient out in two studies: a Phase 1 clinical study of NP001 in patients with Amyotrophic Lateral Sclerosis (ALS, or Lou Gehrig's disease) and a Phase 1/2 clinical study of NP002 in patients with L-dopa-induced dyskinesias (muscle movement disorders).
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sara R Husarik, ARNP 1706 Meridian S, Suite 120, Puyallup, WA 98371-7516 Ph: (253) 848-8797 | Sara R Husarik, ARNP 1706 Meridian S, Suite 120, Puyallup, WA 98371-7516 Ph: (253) 848-8797 |
News Archive
Lenox Hill Radiology, a wholly owned subsidiary of RadNet, Inc., a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of owned and operated outpatient imaging centers, announces that 3D mammography, the latest innovation in breast cancer screening, is now available at its 79th Street location on the Upper West Side.
Champions Biotechnology, Inc., a company engaged in the development of advanced preclinical platforms and tumor specific data to enhance the value of oncology drugs, today announced its financial results for the fiscal year ended April 30, 2010.
Minneapolis Heart Institute Foundation research cardiologist Dr. Michael Miedema is the lead author of a paper published by Circulation - Cardiovascular Imaging, a journal of the American Heart Association, that suggests a connection between an adult's height and the prevalence of coronary artery calcium (CAC), a direct marker of plaque in the arteries that feed the heart.
Neuraltus Pharmaceuticals, a privately held biopharmaceutical company dedicated to developing and commercializing high-impact therapeutics that address critical unmet needs, primarily in the treatment of neurodegenerative diseases, announced today the Company has achieved last patient out in two studies: a Phase 1 clinical study of NP001 in patients with Amyotrophic Lateral Sclerosis (ALS, or Lou Gehrig's disease) and a Phase 1/2 clinical study of NP002 in patients with L-dopa-induced dyskinesias (muscle movement disorders).
› Verified 2 days ago
Melinda Moore, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 6332 Summerwood Dr E, Puyallup, WA 98373 Phone: 253-228-9674 | |
Oscar Herrera, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 220 15th Ave Se, Puyallup, WA 98372 Phone: 253-697-8610 | |
Corene Kimberly Irvin, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 15508 80th Avenue Ct E, Puyallup, WA 98375 Phone: 785-630-0608 | |
Dr. Timothy C Wical Jr., BSN, DNP, PMHNP-BC Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 15406 Meridian E, Puyallup, WA 98375 Phone: 253-509-1777 Fax: 949-577-4515 | |
Jennifer D Anderson, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 118 7th Ave Sw, Puyallup, WA 98371 Phone: 253-579-0067 | |
Christopher Charles Cramer, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1450 5th St Se Ste 4200, Puyallup, WA 98372 Phone: 253-697-3450 | |
Lisa Ann Oberlander, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 11102 Sunrise Blvd E Ste 103, Puyallup, WA 98374 Phone: 253-848-8797 |